Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-β-lactamase-producing Klebsiella pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 1, 2013, Pages 68-73

  Rodriguez Martinez J M ^a   de Alba, P Díaz ^b   Briales, A ^a   Machuca, J ^b   Lossa, M ^c   Fernandez Cuenca F ^b   Baño, J Rodríguez ^a,b   Martinez Martinez L ^d,e   Pascual, A ^a,b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^c Archivo del Ministerio de Asuntos Exteriores y de Cooperación   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

ESBLs; K. Pneumoniae; PMQR

Indexed keywords

BACTERIAL PROTEIN; CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; PLASMID DNA; PROTEIN OQXA; PROTEIN OQXB; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERIUM ISOLATE; CHROMOSOMAL LOCALIZATION; DNA HYBRIDIZATION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GENE EXPRESSION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPAIN;

BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; QUINOLONES;

EID: 84871211006     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks377     Document Type: Article

References (25)

1. Jacoby G, Cattoir V, Hooper D et al. qnr gene nomenclature. Antimicrob Agents Chemother 2008; 52: 2297-9.
2. Rodriguez-Martinez JM, Cano ME, Velasco C et al. Plasmid-mediated quinolone resistance: an update. J Infect Chemother 2011; 17: 149-82.
3. Strahilevitz J, Jacoby GA, Hooper DC et al. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 2009; 22: 664-89.
4. Hansen LH, Jensen LB, Sorensen HI et al. Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J Antimicrob Chemother 2007; 60: 145-7.
5. Hansen LH, Johannesen E, Burmolle M et al. Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob Agents Chemother 2004; 48: 3332-7.
6. Hansen LH, Sorensen SJ, Jorgensen HS et al. The prevalence of the OqxAB multidrug efflux pump amongst olaquindox-resistant Escherichia coli in pigs. Microb Drug Resist 2005; 11: 378-82.
7. Norman A, Hansen LH, She Q et al. Nucleotide sequence of pOLA52: a conjugative IncX1 plasmid from Escherichia coli which enables biofilm formation and multidrug efflux. Plasmid 2008; 60: 59-74.
8. Kim HB, Wang M, Park CH et al. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother 2009; 53: 3582-4.
9. Ruiz de Alegria C, Rodriguez-Bano J, Cano ME et al. Klebsiella pneumoniae strains producing extended-spectrum b-lactamases in Spain: microbiological and clinical features. J Clin Microbiol 2011; 49: 1134-6.
10. Briales A, Rodriguez-Martinez JM, Velasco C et al. Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6′)-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum b-lactamases in Spain. Int J Antimicrob Agents 2012 39: 431-4.
11. Diaz MA, Hernandez-Bello JR, Rodriguez-Bano J et al. Diversity of Escherichia coli strains producing extended-spectrum b-lactamases in Spain: second nationwide study. J Clin Microbiol 2010; 48: 2840-5.
12. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
13. Dhanji H, Patel R, Wall R et al. Variation in the genetic environments of blaCTX-M-15 in Escherichia coli from the faeces of travellers returning to the United Kingdom. J Antimicrob Chemother 2011; 66: 1005-12.
14. Zhao J, Chen Z, Chen S et al. Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment. Antimicrob Agents Chemother 2010; 54: 4219-24.
15. Kieser T. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 1984; 12: 19-36.
16. Carattoli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219-28.
17. Rodriguez-Martinez JM, Velasco C, Pascual A et al. Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids. Clin Microbiol Infect 2006; 12: 440-5.
18. Bialek-Davenet S, Marcon E, Leflon-Guibout V et al. In vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniae. Antimicrob Agents Chemother 2011; 55: 2795-802.
19. Fernandez-Cuenca F, Rodriguez-Martinez JM, Martinez-Martinez L et al. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC b-lactamase. Int J Antimicrob Agents 2006;: 549-52.
20. Yuan J, Xu X, Guo Q et al. Prevalence of the oqxAB gene complex in Klebsiella pneumoniae and Escherichia coli clinical isolates. J Antimicrob Chemother 2012; 67: 1655-9.
21. Veleba M, Higgins PG, Gonzalez G et al. Characterisation of RarA, a novel AraC-family multidrug resistance regulator in Klebsiella pneumoniae. Antimicrob Agents Chemother 2012; 56: 4450-8.
22. Veleba M, Schneiders T. Tigecycline resistance can occur independently of the ramA gene in Klebsiella pneumoniae. Antimicrob Agents Chemother 2012; 56: 4466-7.
23. EUCAST. Disk Diffusion Test for Routine Antimicrobial Susceptibility Testing. http://www.eucast.org/eucast_disk_diffusion_test/(22 January [10,] date last accessed).
24. Briales A, Rodriguez-Martinez JM, Velasco C et al. In vitro effect of qnrA1, qnrB1, and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC. Antimicrob Agents Chemother 2011; 55: 1266-9.
25. Rodriguez-Martinez JM, Briales A, Velasco C et al. Discrepancies in fluoroquinolone clinical categories between the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI for Escherichia coli harbouring qnr genes and mutations in gyrA and parC. J Antimicrob Chemother 2011; 66: 1405-7.